Kimberly Gray, Ms
About Kimberly Gray, Ms
Kimberly Gray is the Planning and Execution Lead at Bristol Myers Squibb in Lawrenceville, New Jersey, with a background in oncology drug discovery, virology, and in vitro cellular pharmacology.
Current Title and Responsibilities
Kimberly Gray currently serves as the Planning and Execution Lead at Bristol Myers Squibb in Lawrenceville, New Jersey. In this role, she is responsible for overseeing project planning and execution strategies, ensuring that timelines are met and operational efficiencies are maintained.
Career at Bristol Myers Squibb
Kimberly Gray has been with Bristol Myers Squibb for over nine years, holding various positions. She began as an Associate Protocol Manager in Plainsboro, New Jersey, from 2014 to 2017. She then advanced to Protocol Manager in Princeton, New Jersey, from 2017 to 2019. Her career progression exemplifies her capability to transition into roles with increasing responsibility and complexity.
Work Experience at Merck
Kimberly Gray worked at Merck, initially as Scientist II in the Virology Drug Discovery department from 2010 to 2011, and later in In Vitro Cellular Pharmacology from 2011 to 2013. Her responsibilities included drug discovery and development, focusing on virology and cellular pharmacology.
Role at Schering-Plough Research Institute
Kimberly Gray accumulated extensive experience in oncology drug discovery during her tenure at Schering-Plough Research Institute. She started as an Associate Scientist from 1995 to 1999, progressed to Scientist I from 2000 to 2005, and finally served as Scientist II from 2006 to 2010. Her work primarily involved developing innovative therapies for cancer treatment.
Educational Background
Kimberly Gray holds a Master of Science (MS) in Biochemistry from Rutgers, The State University of New Jersey-New Brunswick, obtained between 1989 and 1992. She also earned a Bachelor of Arts (BA) in Chemistry from California State University-Long Beach, completing her studies from 1983 to 1987.